In vivo nuclear magnetic resonance spectroscopy can be used to measure intracerebral phenylalanine (Phe) con centrations in patients with phenylketonuria (PKU). Stationary levels, obtained under free nutrition, as well as time courses after an oral Phe load (100 mg/kg) were investigated in 11 PKU patients and were correlated with the individual clinical out come. At blood levels around 1.2 mmollL, brain Phe was 0.41 to 0.73 mmollL in clinically "typical" patients, but less than 0.15 mmollL in three untreated, normally intelligent, adult Phenylketonuria (PKU), caused by a deficiency of the liver enzyme phenylalanine hydroxylase, which converts phenylalanine (Phe) to tyrosine (Tyr), is the most fre quent inborn error of amino acid metabolism with an incidence of 1:8,000 in whites. In untreated classic PKU, this block in the hepatic catabolism of Phe leads to el evated serum levels greater than 1.2 mmol/L (normal value: less than 0.1 mmol/L) with catastrophic conse quences for the developing brain, usually resulting in severe mental and psychomotoric retardation. If patients are subjected to a diet strictly reduced in Phe soon after birth their neurologic and intellectual development is, however, close to normal. Although introduced more than three decades ago, duration and strictness of the diet are still under discussion. Until recently, the policy was to relax the diet after 10 years of age, but current rec-
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ommendations suggest maintaining the strict diet as long as possible (Medical Research Council Working Party on Phenylketonuria, 1993 ).
An individual vulnerability of patients to elevated blood Phe is well known. Several studies demonstrated different degrees of intellectual and neuropsychological deficits, cerebral white matter changes, and EEG abnor malities in patients with PKU who had similar metabolic control (Bick et aI., 1993; Pietz et aI., 1993; Ris et aI., 1994) . Single case reports described untreated patients with classic PKU and normal intelligence (Primrose, 1983) . The pathogenesis of different clinical outcome in spite of comparable blood Phe levels, [Phe]blood ' is still unclear. One possible explanation could be interindivid ual variations in brain concentrations of Phe, which crosses the blood-brain barrier (BBB) slowly, mediated by a saturable transport system.
Since the introduction of newborn screening programs in the mid 1960s, an enlarging number of patients has assembled for whom there is a need to optimize therapy. Dietary compliance is monitored measuring [Phe]hlood by amino acid analysis. Up to now, it had been impossible to give individual diet recommendations. However, this would be most desirable because the burdensome diet is associated with an elevated risk of psychosocial malad justment. Using an animal model of hyperphenylal aninemia, A vison et al. (1990) were able to show that Phe is detectable by J H nuclear magnetic resonance (NMR) spectroscopy in the brain in vivo, providing in tracerebral Phe concentrations, [Phe]brain, which closely correlated with postmortem data. In the meantime, sev eral human studies demonstrated that this technique of fers a new approach for quantifying [Phe]brain noninva sively in PKU patients (Kreis et aI., 1995; MOller et aI., 1995 MOller et aI., , 1997 Novotny et aI., 1995; Pietz et aI., 1995 , Ullrich et aI., 1994 .
During the course of a maternal PKU study, we found three untreated women with classic PKU but normal or nearly normal intelligence. Such highly uncommon cases, which seem to be "protected" without adhering to any diet, are ideally suited for an investigation of the relation between brain Phe and individual vulnerability in PKU. We therefore performed a series of stationary and dynamic NMR experiments to examine the blood brain correlation of Phe concentrations and Phe transport kinetics at the BBB. For comparison, data from two groups of "typical" PKU patients were additionally in cluded in our study.
METHODS

Patient characteristics
Eleven patients were investigated. Genotypes as well as ex tensive blood Phe testing during the years before the examina tion indicated that all patients had classic PKU. None of them had any history of other factors disturbing brain development. Clinical data for all individuals are summarized in Table I . Intelligence quotient (IQ) was tested by the German version of the Wechsler Intelligence Scale (Tewes, 1983; Wechsler, 1991) . Patients of group 1 had never received any dietary treat ment and were still untreated at the time of the study. However, they were almost unaffected clinically and reached normal or nearly normal intelligence scores. Patients of group 2a were untreated in early infancy and were retarded. All subjects of these groups were either born before a screening program had been launched (patients 1-4) or came from a country without systematic newborn screening. Group 2b consisted of early treated adults who had stopped the diet 7 to 20 years ago. Only patient I I reached a good dietary control during the first 10 years of life. Intelligence quotients were within or close to the normal range in this group. Changes with T2-weighted mag netic resonance imaging (MRI) were mildest in the untreated, "atypical" group I. Patients of groups 2a and 2b had abnor malities of cerebral white matter to a variable extent depending on their current diet status. In all individuals, brain NMR spec troscopy yielded normal signal intensities of all routinely ob served metabolites, including N-acetyl-L-aspartate, total cre atine, total choline, and myo-inositol. In blood, all amino acids other than Phe were within the normal range. Informed written consent was obtained in all cases after the nature and possible consequences of the study were fully explained.
Nuclear magnetic resonance spectroscopy
A 1.5 T whole-body NMR imager (MAGNETOM 63 SP, Siemens, Erlangen, Germany) and a standard head coil were used to record localized proton spectra applying the stimulated echo technique (Frahm et a!., 1990) . All spectra were recorded under identical conditions (echo time 20 ms, repetition time 1.6 seconds, 512 acquisitions) and from similar volumes-of-interest (36 cm 3 ) in parieto-occipital peri ventricular brain with pre dominantly white matter. Intracerebral Phe concentrations were determined from difference spectroscopy using spectra from healthy volunteers as a baseline reference as described in detail severe changes, subcortical white matter affected (Bick et aI. , 1993) .
:I: [Phe] bmin at or below limit of detection. § Minimal four blood Phe checks before the beginning of the diet. liOn diet.
'I[ IQ not obtainable because of severe psychomotoric retardation.
elsewhere (Moller et ai., 1995 (Moller et ai., , 1997 . For quantification, the signal from total creatine at 3.0 I ppm was used as an internal reference, and a correction for the normal [Phe]brain in healthy volunteers, which was assumed to be 0.05 mmollL from pre vious biopsy data (McKean, 1972) , was applied. Parallel to NMR spectroscopy, complete blood amino acid profiles, in cluding [Phe]blood' were measured quantitatively by HPLC.
In addition to the measurements of stationary [Phe]brain, time courses of [Phe]blood and [Phe]brain were determined after an oral loading test with L-phenylalanine (100 mg/kg body weight). Five patients could be investigated in this second part of the study, including all clinically unaffected, "atypical" patients as well as patients 8 and 9, serving as clinically' 'typi cal" control subjects. Loading was performed after baseline measurements, and [Phe]blood and [Phe]brain levels were re corded repeatedly starting 1 hour after loading and extending up to 75 hours. The patients had adhered to a fasting period of 12 hours before loading and returned to their normal nutrition (40 to 45 mg Phe per kg body weight per day) after the first postload scan.
Kinetic analysis of time courses
Numerous experimental studies have revealed that the large neutral amino acids are transported across the BBB by means of a common saturable carrier. Because of the competition between amino acids, an apparent Michaelis transport constant, Kt•app, is measured under in vivo conditions, which is deter
where Kt•app is the plasma Phe concentration for half-maximal transport measured in the presence of other competing amino acids sharing the same carrier, K; h e is the absolute Michaelis transport constant for Phe in the absence of competing amino acids, [AA] is the concentration of each competing amino acid, and K� A is the absolute Michaelis constant of each amino acid (Pardridge, 1983) . Recently, we showed that the relationship between [Phe]blood and [Phe]brain can be analyzed quantita tively using a symmetric Michaelis-Menten model and a con stant Phe consumption velocity, Vmet' in the brain cells (Moller et ai., 1997) :
where T m ax is the maximal transport velocity. Phenylalanine transport into and out of the brain is assumed to be character ized by identical kinetic parameters, K t •app and T m a x' Equation 2 may be regarded as the simplest quantitative description of the consequences of amino acid brain uptake and metabolism. Agreement with experimental results was already obtained un der steady-state conditions (Moller et aI., 1997) . The math ematical treatment is equivalent to the standard model of glu cose transport kinetics at the BBB (Lund- Andersen, 1979) ,
which was proven to be useful for the analysis of in vivo NMR data on brain glucose influx and consumption (Gruetter et ai., 1993 (Gruetter et ai., , 1996 Mason et ai., 1993) . A symmetric Michaelis Menten model has also been used previously in computer simu lations of amino acid uptake and metabolic pathways in the brain (Hommes and Lee, 1 990a, 1990b by minimizing the sum of squared residuals, X2, over a grid search (Bevington, 1969) with Kt•app = 0.05 to 5.0 mmollL, Trnax = 0.02 to 2.0 mmol'L-I 'min-l , and v m e t = 0.002 to 0.2 mmol·L -l ·min-I . Estimates of standard deviations were based on the range over which the parameters could be varied without significantly increasing X2. Brain Phe concentrations were determined with an accuracy of approximately ±0.15 mmollL, which was taken into consideration for the error es timation of the kinetic parameters.
RESUL TS AND DISCUSSION
Stationary brain Phe concentrations
In the first part of the study, [Phe]brain was investi gated in all patients while having comparable stationary [Phe]blood around 1.2 mmol/L (mean values ± SD, 1.15 ± 0.10 mmollL in group 1, 1.28 ± 0.06 mmol/L in group 2a, and 1.27 ± 0.09 mmollL in group 2b). Representative spectra are shown in Fig. 1 . Quantitative results are in cluded in Table 1 . As expected, no differences in mean [Phe]brain were observed between groups 2a (0.60 ± 0.04 mmol/L) and 2b (0.59 ± 0.15 mmollL) with typical out comes depending on the individual diet status. Concen tration ratios [Phe]blood/[Phe]brain varied between 1.9 and 2.3 for group 2a and between 1.7 and 2.8 for group 2b, in excellent agreement with results from previous studies (Kreis et aI., 1995; Moller et aI., 1995; Novotny et aI., 1995; Pietz et aI., 1995; Ullrich et aI., 1994) . In contrast, brain Phe was hardly detectable in any of the' 'atypical" patients. Therefore, [Phe]brain must have been less than the estimated detection limit of our method of approxi mately 0.15 mmol/L, which is less than 25% of the mean values observed in the other two groups (P < 0.001). This excellent correlation with the clinical parameters under lines the paramount importance of stationary [Phe]brain as one key explanatory factor for the outcome in classic PKU.
Phenylalanine can interfere with the development and function of the CNS by different mechanisms. However, no single process by itself seems sufficient to explain the brain phenotype in PKU (Scriver et aI., 1995) . High Phe levels in the brain lead to dysmyelination and may also result in decreased neurotransmitter receptor density and cell connectivity (Hommes, 1994) . Besides such mor phologic changes, elevated Phe may cause an imbalance in neurotransmitter metabolism. Phenylalanine inhibits the uptake of the precursor amino acids Tyr and trypto phan into the brain with a resultant loss of dopamine and serotonin and possibly their neuronal release (Paans et aI., 1996) .
Time courses of brain Phe after oral loading
The CNS supply of Phe is a function of the plasma concentration and BBB transport processes. Because all patients presented with almost identical blood levels, we may conclude that the depression in [Phe]brain seen in group 1 is related to transport characteristics. To test this Our data analysis therefore included additional least squares fits to the steady-state solution, equation 3. Re sults are summarized in Fig. 2 and Table 2 . A compari son of the predicted time courses during the initial post load period indicated a delayed response of brain Phe after the rapid change in [Phe ]blood' which confirms pre vious observations (Pietz et aI., 1995) . Although only the more general equation 2 is appropriate to analyze this non-steady-state situation after the load, similar numeri cal results were found with both methods.
The range of velocities for Phe brain transport and consumption obtained with equation 2 from the grid search was T max "" 0.040 to 0.25 mmol·L -1 'min-1 (mean, 0.12 mmol'L-1 'min-1 ) and V me ! "" 0.014 to 0.098 mmol'L-1 'min-1 (mean, 0.046 mmol'L-1 'min-1 ) for group 1, and Tmax "" 0.070 to 0.086 mmol'L-1'min-1 (mean, 0.078 mmol'L-1 'min-1 ) and V me ! "" 0.005 to 0.011 mmol'L-1 'min-1 (mean, 0.008 mmol'L-1 'min-1 ) for group 2. These values should be considered only as rough estimates because large errors have to be consid ered owing to the previously mentioned insufficient time resolution. Hence, the small variation obtained for T max in group 2b may be accidental. Note that large interin dividual variabilities in kinetic parameters were also re ported for healthy volunteers examined with the double indicator technique (Knudsen et aI., 1995) .
Other limitations of determining kinetic parameters Patients reached maximum [Phelb'ood (2.08 to 2.91 mmol/L) within 1 to 4 hours after loading. Similar to the stationary results, post load [Phe]brain in group 1 remained always clearly below val ues observed in the "typical" control patients. Both blood and brain Phe relaxed quicker toward the baseline level in group 1 than in group 2. Besides the experimental [Phelb'ood (open circles) and [Phe]brain data (filled circles), the graphs further show fitted time courses of brain Phe obtained with equation 2 (solid lines) and, under the steady-state approximation, equation 3 (dot ted lines).
from the observed relationship between plasma and brain Phe concentrations may result from several simplifying assumptions inherent in the model function, equation 2, and require further discussion.
First, in the brain, incorporation of Phe into peptides (e.g., ,),-glutamylphenylalanine) or proteins and metabo lite conversions (e.g., via hydroxylation or decarboxyl ation) provide a drain of the Phe level within the cell. In the normal state, the kinetics of the different components of this runout may be described by a Michaelis-Menten model (Kaufman, 1977; Salter et aI., 1986) . In contrast, the overall intracerebral metabolic rate for Phe was as sumed to be constant in equation 2. This seems to be justified, knowing that brain Phe levels are increased by an order of magnitude in classic PKU as compared with healthy controls. Under such conditions we may assume that V me ! approaches its maximal velocity, Vmax. This is consistent with theoretical simulations from rat data for [Phelblood greater than 1 mmolJL (Hommes and Lee, 1990a) . Patients of group 1, however, showed substan tially reduced [Phelbrain even at high blood levels. Al though the quality of the fits did not indicate systematic divergences and the introduction of further variables did not lead to significant reductions in X2, we cannot com pletely exclude the possibility of deviations from a con stant intracerebral metabolic rate in these cases.
Second, another simplification results from the use of a symmetric Michaelis-Menten model for Phe transport at the BBB, which assumes that Phe influx and efflux are characterized by identical kinetic parameters, Kt,a pp and T max' This model has been used successfully to describe steady-state data of Phe transport at the human BBB (MOller et aI., 1997) . Systematic deviations from the pre dicted saturation curve as recently reported for steady state glucose BBB transport (Gruetter et aI., 1997) did not occur in the Phe study, with [Phe]blood ranging from 0.47 to 2.24 mmollL. A symmetric model also agrees perfectly with L-(2-1 8F)-fluorophenylalanine positron emission tomography investigations of amino acid BBB transport in human volunteers (Ito et aI., 1995) , in which identical rate constants were obtained for influx and ef flux. However, we cannot completely exclude the possi bility that gradients in the amino acid concentrations across the BBB lead to differences in Kt,a pp for both transport directions.
The values for Kt,a pp and T maJvmet differ substantially among individuals of the same group. Pooling the data within the two groups to obtain mean values yielded standard deviations similar to those given in Table 2 , which were obtained individually from the experimental accuracy (group 1, Kt,a pp = 0.81 ± 0.33 mmollL, TmaJ vmet = 2.87 ± 0.33; group 2b, Kt,a pp = 0.10 ± 0.04 mmollL, Trna/vrnet = 11.3 ± 4.4; the largest individual error was chosen as "standard deviation" for Kt,a pp in group 2b). Biologic variations may contribute to the ob served range of Kt,a pp and T ma/vmet within the groups.
Further clarification of this point, however, requires larger data sets. Within the limitations of the very small database, statistical comparisons (Student ' s t test) of the mean values indicated that the obtained differences be tween both groups were significant (Kt,a pp , P < 0.04; Tma/vme !' P < 0.03).
The kinetic parameters recorded from group 2 agree well with recent NMR results (Kt,a pp = 0.16 ± 0.11 mmollL; T ma/vme ! = 9.0 ± 4.1) measured in nine clini cally "typical" PKU patients under steady-state condi tions (Moller et aI., 1997) . They are also consistent with the double-indicator measurements after Phe loading in three healthy volunteers, yielding Kt,a pp in a range of 0.03 to 0.58 mmollL and T ma x of 0.0144 to 0.0943 mmol'kg-1 'min-1 (Knudsen et aI., 1995) . In rat parietal cortex, similar values of Kt,a pp of 0.218 ± 0.009 mmollL and T max of 0.041 ± 0.003 mmol'kg-1 'min-1 were deter mined with the in situ brain perfusion technique (Momma et aI., 1987) .
Compared with these data, Kt,a pp appeared to be sig nificantly larger in the "atypical" PKU patients. High BBB transport Michaelis constants make the brain up take of amino acids in these individuals less sensitive to the effects of competition (Choi and Pardridge, 1986) , which correlates well with their almost normal clinical outcome. Transport-induced brain amino acid imbal ances may lead to changes in neurotransmitter metabo-lism and may thus influence brain function. The impor tance of competitive interactions, however, is still un clear. From theoretical calculations it was concluded that transport effects cannot explain Phe neurotoxicity (Hom mes, 1989; Lee, 1990a, 1990b) , although others observed a significant lowering of rat brain Phe after injections of competing large neutral amino acids (Andersen and Avins, 1976) .
The theoretical estimates of Kt,a pp at various concen trations of competing amino acids made by Hommes (1989) using equation 1 and rat data yielded values be tween 0.44 and 1.33 mmollL. This matches the range observed in our study for group 1. Computer simulations demonstrated that variations of Kt,a pp over this range had very little effect on the Phe concentration in the brain.
Hence, differences in Kt,a pp alone seem to be insufficient to explain the low [Phe ] brain values found in group 1.
Our data provide further evidence that the excess of the influx rate over the metabolic rate is substantially reduced in group 1. From the symmetric Michaelis Menten model (equation 2) and our crude estimates of T max and v met values, this reduction in T maJv met seems more likely to be caused by increased brain Phe con sumption rates than depressed Phe influx in the "atypi cal" patients. However, an asymmetric transport at the BBB, with T o ut more than Tin in group 1, might also explain the observed differences. Our I H NMR data do not distinguish between individual processes contribut ing to the drain of the intracerebral Phe level; hence, other methods are needed for further investigation of both alternatives.
In the normal state, dominant contributions to the Phe runout are hydroxylation in the liver and protein incor poration (Kaufman, 1977) . It is still an unsolved question whether alternative pathways, involving transamination or decarboxylation, reflect metabolism in the body or whether it is mainly a metabolic product of bacteria in the gut. However, it has been concluded that such path ways are quantitatively only very minor ones (Kaufman, 1989) . High brain Phe metabolic rates might indicate the intracerebral existence of a genetic enzyme system, re storing a more or less normal amino acid balance via hydroxylation (Kutter, 1978) . Phenylalanine hydroxyl ation in human brain tissue has been reported from im munochemical studies leading to the assumption of an intracerebral isoenzyme of Phe hydroxylase (Bessman et aI., 1977; Chestkov and Laptev, 1988; Petruschka et aI., 1990) , a possibility that was ruled out by others (Abita et aI., 1974; Scriver et aI., 1995) . Alternatively, various areas of brain were shown to contain Tyr hydroxylase, which is capable of catalyzing the conversion of Phe to Tyr at a rate comparable to Tyr hydroxylation (Bagchi and Zarycki, 1973; Ikeda et aI., 1965; Katz et aI., 1976; McGeer et aI., 1971) . Although our NMR results do not provide information about the specific reactions involved in brain Phe metabolism, they are consistent with the assumption that full activity of any of those enzymes would lead to an optimal protection of the brain against neurotoxic consequences of permanently elevated [Phe ]blood' CONCLUSION In summary, our results suggest that interindividual variations in the kinetics of Phe uptake and metabolism do exist, leading to different brain concentrations of the neurotoxin Phe at comparable blood levels. Such varia tions seem to be a major causative factor in the patho genesis of PKU, providing novel insights into the enig matic phenotypic heterogeneity of the disease. An im portant advantage of in vivo NMR spectroscopy, which is widely available, is that the method is essentially nonin vasive. Future use of spectroscopy may include an in vestigation of competition interactions directly in PKU patients by performing Phe loading studies with and without additional application of competing amino acids. Dynamic NMR measurements of [Phe]brain therefore have a potential for optimizing individual treatment strat egies.
